Citi Cuts Dendreon (DNDN) Price Target to $10 Amid 'Significant Threats to Provenge'
Get Alerts DNDN Hot Sheet
Price: $0.13 --0%
Rating Summary:
2 Buy, 15 Hold, 9 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Rating Summary:
2 Buy, 15 Hold, 9 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Join SI Premium – FREE
Shares of Dendreon (Nasdaq: DNDN) are moving higher Thursday morning despite some concerning comments and a reduced price target from Citi's Yaron Werber.
The analyst now sees Dendreon shares rising to $10 over the next year, down from a previous target of $14. Werber sees "significant threats to Provenge" from Johnson & Johnson's (NYSE: JNJ) Zytiga and Medivation's (Nasdaq: MDVN) MDV3100. He said oral drugs may prove to offer a longer overall survival benefit, in addition to being cheaper.
Werber is currently modeling for J&J's Zytiga to be approved for pre-chemo patients in 2013. The analyst expects Medivation's product to be cleared in 2014.
The Citi analyst maintains a Neutral rating on Dendreon shares.
With the stock last trading up 0.5 percent to $9.48, Citi's new target implies potential upside of about 5 percent.
Visit our Analyst Ratings page to track all the market-moving analyst action on shares of Dendreon.
The analyst now sees Dendreon shares rising to $10 over the next year, down from a previous target of $14. Werber sees "significant threats to Provenge" from Johnson & Johnson's (NYSE: JNJ) Zytiga and Medivation's (Nasdaq: MDVN) MDV3100. He said oral drugs may prove to offer a longer overall survival benefit, in addition to being cheaper.
Werber is currently modeling for J&J's Zytiga to be approved for pre-chemo patients in 2013. The analyst expects Medivation's product to be cleared in 2014.
The Citi analyst maintains a Neutral rating on Dendreon shares.
With the stock last trading up 0.5 percent to $9.48, Citi's new target implies potential upside of about 5 percent.
Visit our Analyst Ratings page to track all the market-moving analyst action on shares of Dendreon.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hyundai Mobis Co Ltd. (012330:KS) PT Raised to KRW340,000 at HSBC
- 29Metals Ltd (29M:AU) PT Lowered to AUD0.50 at RBC Capital
- Dollar General (DG) PT Raised to $175 at Argus
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!